Updated consensus guidelines for management of moderate-to-severe atopic dermatitis in Singapore: Integrating biologics, Janus kinase inhibitors and conventional therapies

Updated consensus guidelines for management of moderate-to-severe atopic dermatitis in Singapore: Integrating biologics, Janus kinase inhibitors and conventional therapies

Introduction: Since 2016, several therapies have been approved for treating atopic dermatitis (AD) in Singapore, including biologics, oral Janus kinase (JAK) inhibitors and topical crisaborole. This study supplements the 2016 Singapore treatment guidelines for AD, focusing on newer therapies for mo...

Full description

Saved in:
Bibliographic Details
Main Authors: Yik Weng Yew, Uma Alagappan, Derrick Aw, Suyien Chandran, Karen JL Choo, Roland Chu, Hong Yi Koh, Mark Jean Aan Koh, Shan Xian Lee, Ching Yin Neoh, Siyun Lucinda Tan, Mark Tang, Yong-Kwang Tay, Seth Francis-Graham, Andrew Lim, Haur Yueh Lee
Format: Article
Language:English
Published: Academy of Medicine Singapore 2024-11-01
Series:Annals, Academy of Medicine, Singapore
Online Access:https://annals.edu.sg/updated-consensus-guidelines-for-management-of-moderate-to-severe-atopic-dermatitis-in-singapore-integrating-biologics-janus-kinase-inhibitors-and-conventional-therapies/
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://annals.edu.sg/updated-consensus-guidelines-for-management-of-moderate-to-severe-atopic-dermatitis-in-singapore-integrating-biologics-janus-kinase-inhibitors-and-conventional-therapies/

Similar Items